Worms and tuberculosis vaccines [3]

Trends in Microbiology

Volumn 9, Issue 10, 2001, Pages 474-

  Markus, M B ^a  

^a Consulting Services International ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; DIPHTHERIA VACCINE; TETANUS TOXOID;

AFRICA; BACTERIAL VIRULENCE; BCG VACCINATION; CELLULAR IMMUNITY; DEVELOPING COUNTRY; DRUG EFFICACY; EPIDEMIC; HELMINTHIASIS; HUMAN; INFECTION CONTROL; LETTER; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; WORM INFECTION;

EID: 0035476831     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(01)02172-2     Document Type: Letter

References (10)

1. TB vaccines: Progress and problems
2. Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis
3. Tuberculosis vaccine development: Recent progress
4. Mbeki and AIDS in Africa
5. Implications for neonatal HIV/AIDS and TB of sensitization in utero to helminths
6. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination
7. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR
8. Helminthic infection and HIV vaccine trials
9. Helminthiasis and HIV vaccine efficacy
10. Lower hookworm incidence, prevalence, and intensity of infection in children with a Bacillus Calmette-Guérin vaccination scar